Almokalant

Almokalant
Clinical data
ATC code	None;
Identifiers
	IUPAC name 4-(3-{Ethyl[3-(propane-1-sulfinyl)propyl]amino}-2-hydroxypropoxy)benzonitrile;
CAS Number	123955-10-2 ;
PubChem CID	3033962;
ChemSpider	2298526 ;
UNII	I9NG89L275;
ChEMBL	ChEMBL362103 ;
CompTox Dashboard (EPA)	DTXSID40869693 ;
Chemical and physical data
Formula	C18H28N2O3S
Molar mass	352.5 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=S(CCC)CCCN(CC)CC(O)COc1ccc(C#N)cc1;
	InChI InChI=1S/C18H28N2O3S/c1-3-11-24(22)12-5-10-20(4-2)14-17(21)15-23-18-8-6-16(13-19)7-9-18/h6-9,17,21H,3-5,10-12,14-15H2,1-2H3 ; Key:ZMHOBBKJBYLXFR-UHFFFAOYSA-N ;
	(verify)

Almokalant is drug used to treat arrhythmia.^[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.^[2]

References

^ Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American Heart Journal. 126 (4): 1008–1011. doi:10.1016/0002-8703(93)90726-p.
^ Wellfelt, K.; Sköld, A. C.; Wallin, A.; Danielsson, B. R. (1999-04-01). "Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species". Reproductive Toxicology (Elmsford, N.Y.). 13 (2): 93–101. ISSN 0890-6238. PMID 10213516.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.